Updated Interim Guidance for HCPs: Managing Patients with Suspected EVALI During Flu Season

Because patients with e-cigarette, or vaping, product use-associated lung injury (EVALI) may have similar symptoms to flu or other respiratory illness, diagnosing and managing these patients can be challenging. CDC has provided updated clinical guidelines for evaluating and managing patients with EVALI in the outpatient setting, including specific considerations during flu season.

Update: Interim Guidance for Health Care Providers for Managing Patients with Suspected E-cigarette, or Vaping, Product Use–Associated Lung Injury — United States, November 2019

Weekly / November 22, 2019 / 68(46);1081-1086

On November 19, 2019, this report was posted online as an MMWR Early Release.

Tara C. Jatlaoui, MD1; Jennifer L. Wiltz, MD1; Sarah Kabbani, MD2; David A. Siegel, MD1; Ram Koppaka, MD, PhD3; Michele Montandon, MD4; Susan Hocevar Adkins, MD5; David N. Weissman, MD6; Emily H. Koumans, MD1; Michelle O’Hegarty, PhD1; Megan C. O’Sullivan, MPH2; Matthew D. Ritchey, DPT1; Kevin Chatham-Stephens, MD7; Emily A. Kiernan, DO8,9; Mark Layer, MD9,10; Sarah Reagan-Steiner, MD2; Jaswinder K. Legha, MD11; Katherine Shealy, MPH1; Brian A. King, PhD1; Christopher M. Jones, PharmD, DrPH11; Grant T. Baldwin, PhD11; Dale A. Rose, PhD2; Lisa J. Delaney, MS6; Peter Briss, MD1; Mary E. Evans, MD11; Lung Injury Response Clinical Working Group (View author affiliations)